These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17149862)

  • 1. Biological activity of designed photolabile metal nitrosyls: light-dependent activation of soluble guanylate cyclase and vasorelaxant properties in rat aorta.
    Madhani M; Patra AK; Miller TW; Eroy-Reveles AA; Hobbs AJ; Fukuto JM; Mascharak PK
    J Med Chem; 2006 Dec; 49(25):7325-30. PubMed ID: 17149862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
    Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
    Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide generated by the compound RuBPY promotes the vascular smooth cell membrane hyperpolarization.
    Pereira AC; Lunardi CN; Paulo M; da Silva RS; Bendhack LM
    Eur J Pharm Sci; 2013 Mar; 48(4-5):604-10. PubMed ID: 23333503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
    Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
    Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way.
    Pereira Ade C; Ford PC; da Silva RS; Bendhack LM
    Nitric Oxide; 2011 May; 24(4):192-8. PubMed ID: 21440656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.
    Turgut NH; Temiz TK; Turgut B; Karadas B; Parlak M; Bagcivan I
    Can J Physiol Pharmacol; 2013 Oct; 91(10):797-803. PubMed ID: 24144050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway.
    Lunardi CN; Vercesi JA; da Silva RS; Bendhack LM
    Vascul Pharmacol; 2007; 47(2-3):139-44. PubMed ID: 17602893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation.
    Sherikar A; Dhavale R; Bhatia M
    Curr Mol Pharmacol; 2020; 13(2):126-136. PubMed ID: 31654520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule.
    Foresti R; Hammad J; Clark JE; Johnson TR; Mann BE; Friebe A; Green CJ; Motterlini R
    Br J Pharmacol; 2004 Jun; 142(3):453-60. PubMed ID: 15148243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM; Murad F
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypercholesterolemia on expression and function of vascular soluble guanylyl cyclase.
    Laber U; Kober T; Schmitz V; Schrammel A; Meyer W; Mayer B; Weber M; Kojda G
    Circulation; 2002 Feb; 105(7):855-60. PubMed ID: 11854127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
    Sayed N; Baskaran P; Ma X; van den Akker F; Beuve A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12312-7. PubMed ID: 17636120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfhydration-associated phosphodiesterase 5A dimerization mediates vasorelaxant effect of hydrogen sulfide.
    Sun Y; Huang Y; Yu W; Chen S; Yao Q; Zhang C; Bu D; Tang C; Du J; Jin H
    Oncotarget; 2017 May; 8(19):31888-31900. PubMed ID: 28404873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.